561 related articles for article (PubMed ID: 17868689)
1. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
2. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
Cody V; Luft JR; Pangborn W
Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
[TBL] [Abstract][Full Text] [Related]
3. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
[TBL] [Abstract][Full Text] [Related]
4. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
McIvor RS
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
[TBL] [Abstract][Full Text] [Related]
5. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
[TBL] [Abstract][Full Text] [Related]
6. 2-tier bacterial and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate reductase.
Fossati E; Volpato JP; Poulin L; Guerrero V; Dugas DA; Pelletier JN
J Biomol Screen; 2008 Jul; 13(6):504-14. PubMed ID: 18566481
[TBL] [Abstract][Full Text] [Related]
7. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL
Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460
[TBL] [Abstract][Full Text] [Related]
9. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
Affleck JG; Nowickyj SM; Walker VK
Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
[TBL] [Abstract][Full Text] [Related]
10. Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells.
Yu M; Melera PW
Cancer Res; 1993 Dec; 53(24):6031-5. PubMed ID: 8261418
[TBL] [Abstract][Full Text] [Related]
11. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
12. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K
Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448
[TBL] [Abstract][Full Text] [Related]
13. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
[TBL] [Abstract][Full Text] [Related]
14. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.
Urlaub G; Landzberg M; Chasin LA
Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140
[TBL] [Abstract][Full Text] [Related]
15. In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: potential for clinical application.
Blakley RL; Sorrentino BP
Hum Mutat; 1998; 11(4):259-63. PubMed ID: 9554740
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.
Cody V; Galitsky N; Luft JR; Pangborn W; Blakley RL; Gangjee A
Anticancer Drug Des; 1998 Jun; 13(4):307-15. PubMed ID: 9627670
[TBL] [Abstract][Full Text] [Related]
17. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the gene for human dihydrofolate reductase: an unlikely cause of clinical relapse in pediatric leukemia after therapy with methotrexate.
Spencer HT; Sorrentino BP; Pui CH; Chunduru SK; Sleep SE; Blakley RL
Leukemia; 1996 Mar; 10(3):439-46. PubMed ID: 8642859
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
20. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]